SCHEMBL30282397

SCHEMBL30282397

C#C[C@@](C)(O)c1cc(C(F)F)ncn1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28956074 1.00 — —
SCHEMBL28956162 0.78 CA2 (0.44) —
SCHEMBL30282364 0.78 CA2 (0.44) —
SCHEMBL30282441 0.78 — —
SCHEMBL28956019 0.78 — —
SCHEMBL25207482 0.76 KMT2A (0.30) —
SCHEMBL31708045 0.72 CYP2C19 (0.35) —
SCHEMBL25217067 0.72 CYP2C19 (0.35) —
SCHEMBL28964988 0.70 KMO (0.36) —
SCHEMBL30282551 0.70 KMO (0.36) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4143179-A1 AZETIDIN-3-YLMETHANOL DERIVATIVES AS CCR6 RECEPTOR MODULATORS Idorsia Pharmaceuticals Ltd (CH) 2023-03-08 — — EP disclosed
CN-115551841-A Azetidin-3-ylcarbinol derivatives as modulators of the CCR6 receptor 爱杜西亚药品有限公司 2022-12-30 — — CN disclosed
Send feedback